Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 17:5:1487831.
doi: 10.3389/falgy.2024.1487831. eCollection 2024.

Key differences between chronic inducible and spontaneous urticaria

Affiliations

Key differences between chronic inducible and spontaneous urticaria

Mojca Bizjak et al. Front Allergy. .

Abstract

Introduction: The latest international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for urticaria recommends limited laboratory testing for chronic spontaneous urticaria (CSU) and selective testing for only certain chronic inducible urticaria (CIndU) subtypes, though the rationale for these recommendations is poorly explained. This study aimed to improve the understanding of CIndU subtypes by comprehensively comparing their demographic, clinical, and laboratory characteristics with those of the better-characterized CSU.

Methods: We conducted a retrospective analysis of 567 patients (median age 41 years, 67% female) diagnosed with CSU, symptomatic dermographism (SD), cold urticaria (ColdU), cholinergic urticaria (CholU), and delayed pressure urticaria (DPU).

Results: Our findings revealed that patients with SD, ColdU, and CholU had lower levels of C-reactive protein (CRP), higher total serum immunoglobulin E (IgE) levels, and higher basophil counts compared to CSU patients. These subtypes also had distinct demographic and clinical features, such as a younger age of onset and a longer disease duration. In contrast, patients with DPU had significantly higher CRP levels and neutrophil counts compared to those with CSU.

Discussion: These findings highlight the heterogeneity among chronic urticaria subtypes, suggesting that a tailored approach to laboratory testing may be more effective. The distinct immunological and clinical features observed in CIndU subtypes suggest a need for subtype-specific diagnostic and therapeutic guidelines.

Keywords: C-reactive protein; blood cell count; chronic inducible urticaria; chronic spontaneous urticaria; immunoglobulin E.

PubMed Disclaimer

Conflict of interest statement

MB has been a speaker and advisor for Novartis, outside the submitted work. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of chronic urticaria types and subtypes. Abbreviations: CholU, cholinergic urticaria during all seasons; CIndU, chronic inducible urticaria; CIndU-alone, chronic inducible urticaria without concomitant chronic spontaneous urticaria; ColdUT, typical cold urticaria; ColdU-neg-LCP, cold urticaria with negative local cold provocation tests; CSU, chronic spontaneous urticaria; CSU-alone, chronic spontaneous urticaria without concomitant chronic inducible urticaria; DPU, delayed pressure urticaria; SD, symptomatic dermographism.

References

    1. Fricke J, Avila G, Keller T, Weller K, Lau S, Maurer M, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. (2020) 75:423–32. 10.1111/all.14037 - DOI - PubMed
    1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. (2022) 77:734–66. 10.1111/all.15090 - DOI - PubMed
    1. Buttgereit T, Vera C, Aulenbacher F, Church MK, Hawro T, Asero R, et al. Patients with chronic spontaneous urticaria who have wheals, angioedema, or both, differ demographically, clinically, and in response to treatment-results from CURE. J Allergy Clin Immunol Pract. (2023) 11:3515–25.e4. 10.1016/j.jaip.2023.08.020 - DOI - PubMed
    1. Kolkhir P, Gimenez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers. (2022) 8:61. 10.1038/s41572-022-00389-z - DOI - PubMed
    1. Weller K, Gimenez-Arnau A, Grattan C, Asero R, Mathelier-Fusade P, Bizjak M, et al. The chronic urticaria registry: rationale, methods and initial implementation. J Eur Acad Dermatol Venereol. (2021) 35:721–9. 10.1111/jdv.16947 - DOI - PubMed

LinkOut - more resources